Computed tomography and cardiac magnetic resonance imaging in pulmonary hypertension

Progress in Cardiovascular Diseases

Volumn 55, Issue 2, 2012, Pages 161-171

  Stevens, Gerin R ^a   Fida, Nadia ^a   Sanz, Javier ^b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Computed tomography; Hypertension; Magnetic resonance imaging; Pulmonary; Right ventricle

Indexed keywords

ARTICLE; CARDIOPULMONARY HEMODYNAMICS; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL ASSESSMENT; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; EVALUATION RESEARCH; HEART RIGHT VENTRICLE; HUMAN; INTERMETHOD COMPARISON; LUNG ANGIOGRAPHY; LUNG STRUCTURE; PATIENT SAFETY; PROGNOSIS; PULMONARY ARTERY; PULMONARY HYPERTENSION; SENSITIVITY AND SPECIFICITY;

HEART VENTRICLES; HUMANS; HYPERTENSION, PULMONARY; MAGNETIC RESONANCE IMAGING, CINE; TOMOGRAPHY, X-RAY COMPUTED; VENTRICULAR FUNCTION, RIGHT;

EID: 84866621750     PISSN: 00330620     EISSN: 18731740     Source Type: Journal    
DOI: 10.1016/j.pcad.2012.07.009     Document Type: Article

References (66)

1. Apostolakis S., Konstantinides S. The right ventricle in health and disease: insights into physiology, pathophysiology and diagnostic management. Cardiology 2012, 121:263-273.
2. Champion H.C., Michelakis E.D., Hassoun P.M. Comprehensive invasive and noninvasive approach to the right ventricle-pulmonary circulation unit: state of the art and clinical and research implications. Circulation 2009, 120:992-1007.
3. McLaughlin V.V., Archer S.L., Badesch D.B., et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association. J Am Coll Cardiol 2009, 53:1573-1619.
4. Devaraj A., Hansell D.M. Computed tomography signs of pulmonary hypertension: old and new observations. Clin Radiol 2009, 64:751-760.
5. Benza R., Biederman R., Murali S., et al. Role of cardiac magnetic resonance imaging in the management of patients with pulmonary arterial hypertension. J Am Coll Cardiol 2008, 52:1683-1692.
6. Stevens G.R., Sanz J. Diagnosis of pulmonary hypertension. Expert Opin Med Diagn 2008, 2:1263-1277.
7. Lang I.M., Plank C., Sadushi-Kolici R., et al. Imaging in pulmonary hypertension. JACC Cardiovasc Imaging 2010, 3:1287-1295.
8. Ley S., Kreitner K.-F., Fink C., et al. Assessment of pulmonary hypertension by CT and MR imaging. Eur Radiol 2004, 14:359-368.
9. Sánchez Nistal M.A. Pulmonary hypertension: the contribution of MDCT to the diagnosis of its different types. Radiologia 2010, 52:500-512.
10. Hoey E.T., Gopalan D., Agrawal S.K., et al. Cardiac causes of pulmonary arterial hypertension: assessment with multidetector CT. Eur Radiol 2009, 19:2557-2568.
11. Plumhans C., Muhlenbruch G., Rapaee A., et al. Assessment of global right ventricular function on 64-MDCT compared with MRI. AJR Am J Roentgenol 2008, 190:1358-1361.
12. Nicol E.D., Kafka H., Stirrup J., et al. A single, comprehensive non-invasive cardiovascular assessment in pulmonary arterial hypertension: combined computed tomography pulmonary and coronary angiography. Int J Cardiol 2009, 136:278-288.
13. Guo Y.K., Gao H.L., Zhang X.C., et al. Accuracy and reproducibility of assessing right ventricular function with 64-section multi-detector row CT: comparison with magnetic resonance imaging. Int J Cardiol 2010, 139:254-262.
14. Numburi U.D., Chatzimavroudis G.P., Stillman A.E., et al. Patient-specific contrast injection protocols for cardiovascular multidetector row computed tomography. J Comput Assist Tomogr 2007, 31:281-289.
15. Takakuwa K.M., Halpern E.J., Gingold E.L., et al. Radiation dose in a "Triple Rule-Out" coronary CT angiography protocol of emergency department patients using 64-MDCT: the impact of ECG-based tube current modulation on age, sex, and body mass index. Am J Roentgenol 2009, 192:866-872.
16. Bastarrika G., Lee Y.S., Huda W., et al. CT of coronary artery disease1. Radiology 2009, 253:317-338.
17. Chan A., Juarez M., Shelton D., et al. Novel computed tomographic chest metrics to detect pulmonary hypertension. BMC Med Imaging 2011, 11:7.
18. Okajima Y., Ohno Y., Washko G.R., et al. Assessment of pulmonary hypertension what CT and MRI can provide. Acad Radiol 2011, 18:437-453.
19. Devaraj A., Wells A.U., Meister M.G., et al. Detection of pulmonary hypertension with multidetector CT and echocardiography alone and in combination1. Radiology 2010, 254:609-616.
20. Rajaram S., Swift A.J., Capener D., et al. Comparison of the diagnostic utility of cardiac magnetic resonance imaging, computed tomography, and echocardiography in assessment of suspected pulmonary arterial hypertension in patients with connective tissue disease. J Rheumatol 2012, 39:1265-1274.
21. Froelich J.J., Koenig H., Knaak L., et al. Relationship between pulmonary artery volumes at computed tomography and pulmonary artery pressures in patients with- and without pulmonary hypertension. Eur J Radiol 2008, 67:466-471.
22. Ackman Haimovici J.B., Trotman-Dickenson B., Halpern E.F., et al. Relationship between pulmonary artery diameter at computed tomography and pulmonary artery pressures at right-sided heart catheterization. Acad Radiol 1997, 4:327-334.
23. Simon M.A., Deible C., Mathier M.A., et al. Phenotyping the right ventricle in patients with pulmonary hypertension. Clin Transl Sci 2009, 2:294-299.
24. Groves A.M., Win T., Charman S.C., et al. Semi-quantitative assessment of tricuspid regurgitation on contrast-enhanced multidetector CT. Clin Radiol 2004, 59:715-719.
25. Aviram G., Cohen D., Steinvil A., et al. Significance of reflux of contrast medium into the inferior vena cava on computerized tomographic pulmonary angiogram. Am J Cardiol 2012, 109:432-437.
26. Yeh B.M., Kurzman P., Foster E., et al. Clinical relevance of retrograde inferior vena cava or hepatic vein opacification during contrast-enhanced CT. Am J Roentgenol 2004, 183:1227-1232.
27. Haddad F., Kudelko K., Mercier O., et al. Pulmonary hypertension associated with left heart disease: characteristics, emerging concepts, and treatment strategies. Prog Cardiovasc Dis 2011, 54:154-167.
28. Simonneau G., Robbins I.M., Beghetti M., et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2009, 54:S43-S54.
29. Chandy G. Pulmonary hypertension associated with parenchymal lung disease. Can J Cardiol 2010, 26(Suppl B):21B-23B.
30. Grosse C., Grosse A. CT findings in diseases associated with pulmonary hypertension: a current review. Radiographics 2010, 30:1753-1777.
31. Beauchesne L.M., Dennie C.J. Imaging in pulmonary hypertension: echocardiography, computed tomography and cardiac magnetic resonance imaging. Can J Cardiol 2010, 26(Supplement B):17B-20B.
32. Castañer E., Gallardo X., Ballesteros E., et al. CT diagnosis of chronic pulmonary thromboembolism. Radiographics 2009, 29:31-50.
33. Willemink M.J., van Es H.W., Koobs L., et al. CT evaluation of chronic thromboembolic pulmonary hypertension. Clin Radiol 2012, 67:277-285.
34. King M.A., Ysrael M., Bergin C.J. Chronic thromboembolic pulmonary hypertension: CT findings. Am J Roentgenol 1998, 170:955-960.
35. Grothues F., Moon J.C., Bellenger N.G., et al. Interstudy reproducibility of right ventricular volumes, function, and mass with cardiovascular magnetic resonance. Am Heart J 2004, 147:218-223.
36. van Wolferen S.A., Marcus J.T., Boonstra A., et al. Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension. Eur Heart J 2007, 28:1250-1257.
37. Freed B., Gomberg-Maitland M., Chandra S., et al. Late gadolinium enhancement cardiovascular magnetic resonance predicts clinical worsening in patients with pulmonary hypertension. J Cardiovasc Magn Reson 2012, 14:11.
38. Saba T.S., Foster J., Cockburn M., et al. Ventricular mass index using magnetic resonance imaging accurately estimates pulmonary artery pressure. Eur Respir J 2002, 20:1519-1524.
39. Gan C.T.-J., Holverda S., Marcus J.T., et al. Right ventricular diastolic dysfunction and the acute effects of sildenafil in pulmonary hypertension patients. Chest 2007, 132:11-17.
40. Alunni J.-P., Degano B., Arnaud C., et al. Cardiac MRI in pulmonary artery hypertension: correlations between morphological and functional parameters and invasive measurements. Eur Radiol 2010, 20:1149-1159.
41. Marcus J.T., Anton Vonk N., Roeleveld R.J., et al. Impaired left ventricular filling due to right ventricular pressure overload in primary pulmonary hypertension: noninvasive monitoring using MRI. Chest 2001, 119:1761-1765.
42. Dellegrottaglie S., Sanz J., Poon M., et al. Pulmonary hypertension: accuracy of detection with left ventricular septal-to-free wall curvature ratio measured at cardiac MR. Radiology 2007, 243:63-69.
43. Roeleveld R.J., Marcus J.T., Faes T.J.C., et al. Interventricular septal configuration at MR imaging and pulmonary arterial pressure in pulmonary hypertension1. Radiology 2005, 234:710-717.
44. Blyth K.G., Groenning B.A., Martin T.N., et al. Contrast enhanced-cardiovascular magnetic resonance imaging in patients with pulmonary hypertension. Eur Heart J 2005, 26:1993-1999.
45. McCann G.P., Gan C.T., Beek A.M., et al. Extent of MRI delayed enhancement of myocardial mass is related to right ventricular dysfunction in pulmonary artery hypertension. Am J Roentgenol 2007, 188:349-355.
46. Sanz J., Dellegrottaglie S., Kariisa M., et al. Prevalence and correlates of septal delayed contrast enhancement in patients with pulmonary hypertension†;. Am J Cardiol 2007, 100:731-735.
47. Shehata M.L., Lossnitzer D., Skrok J., et al. Myocardial delayed enhancement in pulmonary hypertension: pulmonary hemodynamics, right ventricular function, and remodeling. AJR Am J Roentgenol 2011, 196:87-94.
48. Sanz J., Kuschnir P., Rius T., et al. Pulmonary arterial hypertension: noninvasive detection with phase-contrast MR imaging. Radiology 2007, 243:70-79.
49. Moral S., Fernandez-Friera L., Stevens G., et al. New index alpha improves detection of pulmonary hypertension in comparison with other cardiac magnetic resonance indices. Int J Cardiol 2011, [Epub May 18, 2011].
50. García-Alvarez A., Fernández-Friera L., Mirelis J.G., et al. Non-invasive estimation of pulmonary vascular resistance with cardiac magnetic resonance. Eur Heart J 2011, 32:2438-2445.
51. Sanz J., Garcia-Alvarez A., Fernandez-Friera L., et al. Right ventriculo-arterial coupling in pulmonary hypertension: a magnetic resonance study. Heart 2012, 98:238-243.
52. Sanz J., Kariisa M., Dellegrottaglie S., et al. Evaluation of pulmonary artery stiffness in pulmonary hypertension with cardiac magnetic resonance. JACC Cardiovasc Imaging 2009, 2:286-295.
53. Stevens G.R., Lala A., Sanz J., et al. Exercise performance in patients with pulmonary hypertension linked to cardiac magnetic resonance measures. J Heart Lung Transplant 2009, 28:899-905.
54. Kang K.W., Chang H.J., Kim Y.J., et al. Cardiac magnetic resonance imaging-derived pulmonary artery distensibility index correlates with pulmonary artery stiffness and predicts functional capacity in patients with pulmonary arterial hypertension. Circ J 2011, 75:2244-2251.
55. Stevens G.R., Garcia-Alvarez A., Sahni S., et al. RV dysfunction in pulmonary hypertension is independently related to pulmonary artery stiffness. J Am Coll Cardiol Image 2012, 5:378-387.
56. Mahapatra S., Nishimura R.A., Sorajja P., et al. Relationship of pulmonary arterial capacitance and mortality in idiopathic pulmonary arterial hypertension. J Am Coll Cardiol 2006, 47:799-803.
57. Gan C.T.-J., Lankhaar J.-W., Westerhof N., et al. Noninvasively assessed pulmonary artery stiffness predicts mortality in pulmonary arterial hypertension. Chest 2007, 132:1906-1912.
58. Benza R.L., Miller D.P., Gomberg-Maitland M., et al. Predicting survival in pulmonary arterial hypertension. Circulation 2010, 122:164-172.
59. Kreitner K.-F., Kunz R., Ley S., et al. Chronic thromboembolic pulmonary hypertension-assessment by magnetic resonance imaging. Eur Radiol 2007, 17:11-21.
60. Rajaram S., Swift A., Capener D., et al. Diagnostic accuracy of contrast-enhanced MR angiography and unenhanced proton MR imaging compared with CT pulmonary angiography in chronic thromboembolic pulmonary hypertension. Eur Radiol 2012, 22:310-317.
61. Jeong H.J., Vakil P., Sheehan J.J., et al. Time-resolved magnetic resonance angiography: evaluation of intrapulmonary circulation parameters in pulmonary arterial hypertension. J Magn Reson Imaging 2011, 33:225-231.
62. Nikolaou K., Schoenberg S.O., Attenberger U., et al. Pulmonary arterial hypertension: diagnosis with fast perfusion MR imaging and high-spatial-resolution MR angiography-preliminary experience1. Radiology 2005, 236:694-703.
63. Ohno Y., Hatabu H., Murase K., et al. Quantitative assessment of regional pulmonary perfusion in the entire lung using three-dimensional ultrafast dynamic contrast-enhanced magnetic resonance imaging: preliminary experience in 40 subjects. J Magn Reson Imaging 2004, 20:353-365.
64. Kuehne T., Yilmaz S., Steendijk P., et al. Magnetic resonance imaging analysis of right ventricular pressure-volume loops: in vivo validation and clinical application in patients with pulmonary hypertension. Circulation 2004, 110:2010-2016.
65. Kuehne T., Yilmaz S., Schulze-Neick I., et al. Magnetic resonance imaging guided catheterisation for assessment of pulmonary vascular resistance: in vivo validation and clinical application in patients with pulmonary hypertension. Heart 2005, 91:1064-1069.
66. Bauman G., Scholz A., Rivoire J., et al. Lung ventilation- and perfusion-weighted Fourier decomposition magnetic resonance imaging: in vivo validation with hyperpolarized 3He and dynamic contrast-enhanced MRI. Magn Reson Med 2012, [Epub March 5, 2012].